Found 4 results
Author [ Title(Desc)] Type Year
Filters: Author is Dashwood, RH  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
D
R. H. Dashwood, Myzak, M. C., and Ho, E., “Dietary HDAC inhibitors: Time to rethink weak ligands for cancer prevention”, Carcinogenesis, vol. 27, no. 2, pp. 344-9, 2006.
S
M. C. Myzak, Hardin, K., Dashwood, R. H., and Ho, E., “Sulforaphane Inhibits Histone Deacetylase Activity in BPH-1, LnCaP, and PC-3 Prostate Epithelial Cells”, Carcinogenesis, vol. 27, no. 4, pp. 811-819, 2006.
M. C. Myzak, Tong, P., Dashwood, W. M., Dashwood, R. H., and Ho, E., “Sulforaphane retards the growth of human PC-3 prostate cancer xenografts and inhibits HDAC activity in human subjects”, Experimental Biology and Medics, vol. 232, no. 2, pp. 227-234, 2007.
M. C. Myzak, Orner, G. A., Ho, E., and Dashwood, R. H., “Sulforaphane suppresses tumorigenesis in Apcmin mice via inhibition of histone deacetylase”, The Federation of American Societies for Experimental Biology, vol. 20, no. 3, pp. 506-8, 2006.